212 related articles for article (PubMed ID: 19020999)
1. RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.
Zhang HY; Jin L; Stilling GA; Ruebel KH; Coonse K; Tanizaki Y; Raz A; Lloyd RV
Endocrine; 2009 Feb; 35(1):101-11. PubMed ID: 19020999
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
[TBL] [Abstract][Full Text] [Related]
3. Expression of galectin-3 in skeletal tissues is controlled by Runx2.
Stock M; Schäfer H; Stricker S; Gross G; Mundlos S; Otto F
J Biol Chem; 2003 May; 278(19):17360-7. PubMed ID: 12604608
[TBL] [Abstract][Full Text] [Related]
4. Identification and consequences of galectin-3 expression in pituitary tumors.
Righi A; Jin L; Zhang S; Stilling G; Scheithauer BW; Kovacs K; Lloyd RV
Mol Cell Endocrinol; 2010 Sep; 326(1-2):8-14. PubMed ID: 20451577
[TBL] [Abstract][Full Text] [Related]
5. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
[TBL] [Abstract][Full Text] [Related]
6. Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.
Li X; Hoeppner LH; Jensen ED; Gopalakrishnan R; Westendorf JJ
J Cell Biochem; 2009 Oct; 108(2):378-87. PubMed ID: 19585539
[TBL] [Abstract][Full Text] [Related]
7. The role for runt related transcription factor 2 (RUNX2) as a transcriptional repressor in luteinizing granulosa cells.
Park ES; Park J; Franceschi RT; Jo M
Mol Cell Endocrinol; 2012 Oct; 362(1-2):165-75. PubMed ID: 22713854
[TBL] [Abstract][Full Text] [Related]
8. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.
Voronov D; Gromova A; Liu D; Zoukhri D; Medvinsky A; Meech R; Makarenkova HP
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3115-25. PubMed ID: 23532528
[TBL] [Abstract][Full Text] [Related]
10. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.
Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434
[TBL] [Abstract][Full Text] [Related]
11. Runx2 is expressed in human glioma cells and mediates the expression of galectin-3.
Vladimirova V; Waha A; Lückerath K; Pesheva P; Probstmeier R
J Neurosci Res; 2008 Aug; 86(11):2450-61. PubMed ID: 18438928
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of galectin-3 in pituitary tumors.
Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
[TBL] [Abstract][Full Text] [Related]
14. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis.
Wang Y; Belflower RM; Dong YF; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2005 Sep; 20(9):1624-36. PubMed ID: 16059634
[TBL] [Abstract][Full Text] [Related]
15. RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency.
Kaur G; Jalagadugula G; Mao G; Rao AK
Blood; 2010 Apr; 115(15):3128-35. PubMed ID: 20181616
[TBL] [Abstract][Full Text] [Related]
16. Runx1 and Runx2 cooperate during sternal morphogenesis.
Kimura A; Inose H; Yano F; Fujita K; Ikeda T; Sato S; Iwasaki M; Jinno T; Ae K; Fukumoto S; Takeuchi Y; Itoh H; Imamura T; Kawaguchi H; Chung UI; Martin JF; Iseki S; Shinomiya K; Takeda S
Development; 2010 Apr; 137(7):1159-67. PubMed ID: 20181744
[TBL] [Abstract][Full Text] [Related]
17. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
18. Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma.
Kaptan E; Sancar Bas S; Sancakli A; Aktas HG; Bayrak BB; Yanardag R; Bolkent S
J Cell Biochem; 2017 Nov; 118(11):3911-3919. PubMed ID: 28390192
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2.
Bertrand-Philippe M; Ruddell RG; Arthur MJ; Thomas J; Mungalsingh N; Mann DA
J Biol Chem; 2004 Jun; 279(23):24530-9. PubMed ID: 15051730
[TBL] [Abstract][Full Text] [Related]
20. Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression profiling.
Ruebel KH; Leontovich AA; Tanizaki Y; Jin L; Stilling GA; Zhang S; Coonse K; Scheithauer BW; Lombardero M; Kovacs K; Lloyd RV
Endocrine; 2008 Feb; 33(1):62-76. PubMed ID: 18401765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
